Autor der Publikation

Dose-response relationship of complementary radiotherapy following four cycles of combination chemotherapy in intermediate-stage Hodgkin's disease

, , , , , , , , , , , , , , , , , , , , , , , , und . Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 15 (6): 2275–2287 (1997)

Bitte wählen Sie eine Person um die Publikation zuzuordnen

Um zwischen Personen mit demselben Namen zu unterscheiden, wird der akademische Grad und der Titel einer wichtigen Publikation angezeigt. Zudem lassen sich über den Button neben dem Namen einige der Person bereits zugeordnete Publikationen anzeigen.

 

Weitere Publikationen von Autoren mit dem selben Namen

BEACOPP: a new regimen for advanced Hodgkin's disease. German Hodgkin's Lymphoma Study Group, , , , , , , , , und 15 andere Autor(en). Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, (1998)Low-dose radiation is sufficient for the noninvolved extended-field treatment in favorable early-stage Hodgkin's disease: long-term results of a randomized trial of radiotherapy alone, , , , , , , , , und 19 andere Autor(en). Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 19 (11): 2905–2914 (2001)Resonances and emission patterns of optical microdisk resonators with scatterers., , und . ICTON, Seite 1-4. IEEE, (2015)BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced-stage Hodgkin's lymphoma: interim report from a trial of the German Hodgkin's Lymphoma Study Group, , , , , , , , , und 15 andere Autor(en). Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 16 (12): 3810–3821 (1998)Treatment of advanced Hodgkin's disease with COPP/ABV/IMEP versus COPP/ABVD and consolidating radiotherapy: final results of the German Hodgkin's Lymphoma Study Group HD6 trial, , , , , , , , , und 21 andere Autor(en). Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 15 (2): 276–282 (2004)Further chemotherapy versus low-dose involved-field radiotherapy as consolidation of complete remission after six cycles of alternating chemotherapy in patients with advance Hodgkin's disease. German Hodgkins' Study Group (GHSG), , , , , , , , , und . Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 6 (9): 901–910 (1995)BEACOPP: an intensified chemotherapy regimen in advanced Hodgkin's disease. The German Hodgkin's Lymphoma Study Group, , , , , , , , , und 1 andere Autor(en). Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 8 (2): 143–148 (1997)Moderate dose escalation for advanced stage Hodgkin's disease using the bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone scheme and adjuvant radiotherapy: a study of the German Hodgkin's Lymphoma Study Group, , , , , , , , , und 10 andere Autor(en). Blood, 92 (12): 4560–4567 (1998)Dose-response relationship of complementary radiotherapy following four cycles of combination chemotherapy in intermediate-stage Hodgkin's disease, , , , , , , , , und 15 andere Autor(en). Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 15 (6): 2275–2287 (1997)Colorectal cancer atlas: An integrative resource for genomic and proteomic annotations from colorectal cancer cell lines and tissues., , , , , , , , , und 5 andere Autor(en). Nucleic Acids Res., 44 (Database-Issue): 969-974 (2016)